Research has also investigated blood-derived exosomes as potential biomarkers for AD, focusing on the levels of Aβ, amyloid precursor protein (APP) fragments, tau, and phosphorylated tau (p-tau) [16,17,20]. This evidence concerns the gene APP and Alzheimer disease.